BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16179349)

  • 1. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
    Lukong KE; Larocque D; Tyner AL; Richard S
    J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
    Lukong KE; Huot ME; Richard S
    Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
    Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
    J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.
    Derry JJ; Richard S; Valderrama Carvajal H; Ye X; Vasioukhin V; Cochrane AW; Chen T; Tyner AL
    Mol Cell Biol; 2000 Aug; 20(16):6114-26. PubMed ID: 10913193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
    Lukong KE; Richard S
    Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.
    Locatelli A; Lofgren KA; Daniel AR; Castro NE; Lange CA
    Horm Cancer; 2012 Apr; 3(1-2):14-25. PubMed ID: 22124844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
    Weaver AM; Silva CM
    Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
    Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
    J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
    Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
    Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
    PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.
    Ikeda O; Mizushima A; Sekine Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    Cancer Sci; 2011 Apr; 102(4):756-61. PubMed ID: 21205088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
    Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
    Fan G; Aleem S; Yang M; Miller WT; Tonks NK
    J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.
    Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between Brk kinase and insulin receptor substrate-4.
    Qiu H; Zappacosta F; Su W; Annan RS; Miller WT
    Oncogene; 2005 Aug; 24(36):5656-64. PubMed ID: 15870689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brk/PTK6 signaling in normal and cancer cell models.
    Ostrander JH; Daniel AR; Lange CA
    Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.